Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates

Author： Jin H.   Cheng X.   Traina-Dorge V.L.   Park H.J.   Zhou H.   Soike K.   Kemble G.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.25, 2003-09, pp. : 3647-3652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine

By Herlocher M.L.   Ewasyshyn M.   Sambhara S.   Gharaee-Kermani M.   Cho D.   Lai J.   Klein M.   Maassab H.F.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 172-181

Elsevier

Access to resources Recommend Favorite

Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na

By Goestch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Haeuw J.F.   Nguyen T.   Bonnefoy J.Y.   Corvaa N.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2648-2655

Elsevier

Access to resources Recommend Favorite

The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations

By Juhasz K.   Whitehead S.S.   Boulanger C.A.   Firestone C.-Y.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1416-1424

Elsevier

Access to resources Recommend Favorite

Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus

By Hsu K.-H.L.   Crowe J.E.   Lubeck M.D.   Davis A.R.   Hung P.P.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 509-515

Elsevier

Access to resources Recommend Favorite